La Rosa Holdings Corp. enters May with a toxic combination of headline risk, a Nasdaq compliance warning, and borrowing costs running near 300% — a setup that explains the stock's 68% collapse over the past month.
The catalyst is a restatement. On April 24, La Rosa announced it would restate revenue and cost of revenue for fiscal years 2023 and 2024, cutting gross property management fee revenue by $10.8 million for FY2024 alone — dropping the restated figure to $58.6 million. The company simultaneously flagged material weaknesses in internal controls and identified remediation steps. The announcement triggered the stock's latest leg down and prompted Nasdaq to issue a non-compliance notification on April 22, the same week the reverse split took effect.
The lending market tells a story of extreme stress that preceded the restatement. Cost to borrow has been running above 290% APR for the past week — nearly 40% higher than the 210% levels seen in early April. That is not a normal borrowing environment for a micro-cap real estate services company. Availability remains tight enough to sustain those rates. The borrow picture reflects a market that saw this situation developing well before the accounting news dropped publicly.
Short interest data has whipsawed violently, and the extremes require context. The 1-for-10 reverse split, effective April 20, created a sharp mechanical distortion in share-count-based metrics. Before the split, estimated shares short peaked above 1.4 million in mid-April before collapsing. After the split, the adjusted count has crept back up — rising from roughly 5,900 shares on April 27 to 20,200 on April 30. Expressed as a percentage of the float, short interest now measures 45.9%, a level that reflects both a genuinely small tradeable float and active directional conviction. The ORTEX short score has held above 75 all week, closing at 78 on April 30.
The institutional picture confirms how thinly held this stock is. The top reported institutional holder, SZOP Multistrat Management LLC, controls roughly 11% of shares, followed by Hudson River Trading at just over 9%. Those are the kind of concentrated positions typical of a name with minimal liquidity depth. Joseph La Rosa, the founder, chairman, and CEO, reduced his direct holding at a reported price of $1,000 per share in January — a price point that suggests the trade was filed pre-split, with the post-split equivalent near $100 per share. The CTO, Alex Santos, has been a steady seller of small award tranches over the past two years.
Earnings history offers limited comfort. The most recent print on April 24 sent the stock down 1% on the day and 8% over the following week. The November 2025 result was far more damaging — the stock dropped 20% the day of the announcement and lost nearly 29% over five days. Two of the last four events have produced sharp multi-day declines. With no confirmed next earnings date, the restatement process and the pace of remediation disclosures are now the primary events to track.
The ORTEX short score at 78, a cost to borrow near 300%, and a Nasdaq delisting clock all running simultaneously means the next material development for LRHC is likely a regulatory or accounting filing — and how management communicates the internal control remediation timeline will determine whether the borrowing pressure intensifies further.
See the live data behind this article on ORTEX.
Open LRHC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
